Tracker hits 20,000 innovations

otcinaction

Our sister product OTC New Products Tracker has hit a significant milestone – 20,000 innovations added to a database that tracks consumer healthcare launch activity all the way back to the start of 2013, across 20 key markets. In this week’s blog, we look back at some of the highest-ranked innovations added to the archive over the past year.

A recent 4-star innovation is medical device Flow from Flow Neuroscience, a first of its kind home treatment on the European market. Positioned as a non-medicated alternative treatment for depression, the medical device comprises a brain stimulation headset and a therapy app. While stimulation is in use, the app acts as a virtual therapist that the user can interact with. Available in the UK since summer 2019, Flow retails for £399.

33381-original.jpg

Adjacent OTC categories have been fuelling the fire of consumer healthcare innovation in recent years, with medical cannabis / CBD and probiotics two of the most active categories in terms of launch activity. US marketer CBDfx is arguably the most pioneering innovator among the new wave of medical cannabis companies, launching several new delivery formats over the past two years, including vaping pens (January 2018), “chill shot” drinks for anxiety (March 2019), sublingual hemp strips (April 2019) and acne face masks (June 2019).

Like CBD, probiotics have also enjoyed high levels of innovation in terms of delivery formats and positioning. Two examples of probiotics targeting a new consumer healthcare niche include Elebiotic, a recent Recordati launch in Spain positioned to manage recurrent acute otitis media in infants, and Khan’s Morning, a probiotic launched in South Korea in early 2019 that is claimed to help break down the alcohol and acetaldehyde that causes hangovers.

Review 20,000+ launches and innovations with OTC New Products Tracker, the ultimate competitive intelligence tool! Products are graded with a star rating, from 1* (essentially “me too” and generics) up to 4* (1st Rx-to-OTC switches in a category, creation of a new OTC class or other major leaps in innovation). With a recently-released major update including eye-catching new graphics and powerful search filters that help you visualise and explore the vast archive according to your exact specifications, now is the perfect time to set up your free trial. For a demo or more information, please contact waisan.lee-gabell@NicholasHall.com.

OTCs in Action Episode 48: Will increased Chinese OTC demand boost sales in Japan?

OTCinActionheaderThis week, OTCs are in Action in China, where the termination of the one-child limit will slightly increase demand for children’s OTCs. However, this will not only impact the Chinese OTC market, but neighbouring countries as well. Many younger, affluent Chinese consumers prefer fast-acting Western medicines to locally-manufactured OTCs and Traditional Chinese Medicine, but the lengthy, complex and expensive registration process deters many companies from entering the market.

Because of this, many Chinese tourists are buying OTCs in Japan, Hong Kong and other countries, according to the October issue of Nicholas Hall’s OTC INSIGHT Asia-Pacific. Neighbouring countries are welcoming these consumers with a variety of incentives:

Japan’s National Tourism Organisation reported that relaxed regulations for travel, depreciation of the yen and the MERS outbreak in South Korea were among the factors increasing the number of Chinese visitors to the country by 134% in the year to May 2015.

This increase in travel, coupled with last October’s consumption tax exemption for foreign visitors buying OTC medicines, has led several drugstore chains to adapt their stores in tourist hotspot areas to attract overseas consumers. In particular, leading chain Matsumotokiyoshi announced in late 2014 that it was planning to open 20 duty-free drugstores aimed at foreign shoppers, with all expected to be operational by March 2016.

Additionally, industry sources estimate that purchases by consumers from China account for 50-70% of OTC sales in Hong Kong. Planograms in chain drugstores appeal to them — large SKUs of infant milk powder and other products are shelved in high profile areas.

To see samples from OTC INSIGHT Asia-Pacific, click here.

With nearly 1.4bn residents, China is the world’s most populous country, albeit with a scarcity of children. To learn more about this emerging market, join us in Shanghai as Lynn Xu – Senior VP, Greater China Practice Leader at Nielsen, Jeff Crowther, Executive Director at US-China Health Products Association, and the Nicholas Hall team host the OTC Action Workshop. Click the link for more details: OTC Action Workshop Shanghai

Hello and best wishes for 2014 from INSIGHT Asia-Pacific

Nicola INSIGHT Header 2014

The start of a new year is the ideal time to reflect on events of the previous 12 months and consider what might happen in the year ahead. INSIGHT Asia-Pacific has done just that in the just-published January edition by asking industry experts to share their views on the major trends & developments and their likely impacts in core regional OTC markets.

Continue reading